Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus
- PMID: 8467609
- DOI: 10.1007/BF02231555
Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus
Abstract
In order to investigate, if complement levels can be used as an indicator of clinical activity in systemic lupus erythematosus (SLE), levels of C3, C4, CH50, and C3d were measured in 79 patients, 41 with inactive, 31 with moderately active and 7 with severely active disease. Our study shows that C3d, and particularly the C3d/C3 ratio, provide sensitive markers for disease activity in SLE. Since C3d is a direct measurement of complement turnover, it reflects complement activation better than C3, C4 and CH50.
Similar articles
-
Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.Arthritis Rheum. 1996 Jul;39(7):1178-88. doi: 10.1002/art.1780390716. Arthritis Rheum. 1996. PMID: 8670328
-
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.Arthritis Rheum. 2010 Mar;62(3):837-44. doi: 10.1002/art.27267. Arthritis Rheum. 2010. PMID: 20187154 Free PMC article.
-
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.Ann Rheum Dis. 1988 Nov;47(11):913-7. doi: 10.1136/ard.47.11.913. Ann Rheum Dis. 1988. PMID: 3264693 Free PMC article.
-
Systemic lupus erythematosus.Pediatr Ann. 1982 Apr;11(4):397-402. doi: 10.3928/0090-4481-19820401-10. Pediatr Ann. 1982. PMID: 6179034 Review. No abstract available.
-
Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):183-7. doi: 10.1111/j.1600-0897.1992.tb00787.x. Am J Reprod Immunol. 1992. PMID: 1285875 Review.
Cited by
-
Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.EMBO Mol Med. 2022 Jan 11;14(1):e14182. doi: 10.15252/emmm.202114182. Epub 2021 Nov 29. EMBO Mol Med. 2022. PMID: 34842342 Free PMC article.
-
Systemic complement activation in central serous chorioretinopathy.PLoS One. 2017 Jul 3;12(7):e0180312. doi: 10.1371/journal.pone.0180312. eCollection 2017. PLoS One. 2017. PMID: 28671968 Free PMC article.
-
Clinical utility of complement assessment.Clin Diagn Lab Immunol. 1995 Sep;2(5):509-17. doi: 10.1128/cdli.2.5.509-517.1995. Clin Diagn Lab Immunol. 1995. PMID: 8548527 Free PMC article. Review. No abstract available.
-
Systemic complement activation levels in Stargardt disease.PLoS One. 2021 Jun 25;16(6):e0253716. doi: 10.1371/journal.pone.0253716. eCollection 2021. PLoS One. 2021. PMID: 34170959 Free PMC article. Clinical Trial.
-
Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis.J Neurosci. 2011 Mar 16;31(11):3981-9. doi: 10.1523/JNEUROSCI.3617-10.2011. J Neurosci. 2011. PMID: 21411641 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous